These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24388862)

  • 81. Impact of five tobacco endgame strategies on future smoking prevalence, population health and health system costs: two modelling studies to inform the tobacco endgame.
    van der Deen FS; Wilson N; Cleghorn CL; Kvizhinadze G; Cobiac LJ; Nghiem N; Blakely T
    Tob Control; 2018 May; 27(3):278-286. PubMed ID: 28647728
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cost-effectiveness of a community anti-smoking campaign targeted at a high risk group in London.
    Stevens W; Thorogood M; Kayikki S
    Health Promot Int; 2002 Mar; 17(1):43-50. PubMed ID: 11847137
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A review of economic evaluations of tobacco control programs.
    Kahende JW; Loomis BR; Adhikari B; Marshall L
    Int J Environ Res Public Health; 2009 Jan; 6(1):51-68. PubMed ID: 19440269
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cost-effectiveness analysis of population-based tobacco control strategies in the prevention of cardiovascular diseases in Tanzania.
    Ngalesoni F; Ruhago G; Mayige M; Oliveira TC; Robberstad B; Norheim OF; Higashi H
    PLoS One; 2017; 12(8):e0182113. PubMed ID: 28767722
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Health Benefits and Cost-Effectiveness of Brief Clinician Tobacco Counseling for Youth and Adults.
    Maciosek MV; LaFrance AB; Dehmer SP; McGree DA; Xu Z; Flottemesch TJ; Solberg LI
    Ann Fam Med; 2017 Jan; 15(1):37-47. PubMed ID: 28376459
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation.
    Coyle K; Coyle D; Lester-George A; West R; Nemeth B; Hiligsmann M; Trapero-Bertran M; Leidl R; Pokhrel S;
    Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):7-18. PubMed ID: 28833765
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Understanding the multitude of barriers that prevent smokers in lower socioeconomic groups from accessing smoking cessation support: A literature review.
    van Wijk EC; Landais LL; Harting J
    Prev Med; 2019 Jun; 123():143-151. PubMed ID: 30902700
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effect of Tobacco Control Policies on Information Seeking for Smoking Cessation in the Netherlands: A Google Trends Study.
    Troelstra SA; Bosdriesz JR; de Boer MR; Kunst AE
    PLoS One; 2016; 11(2):e0148489. PubMed ID: 26849567
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cost-effectiveness of a school-based tobacco-use prevention program.
    Wang LY; Crossett LS; Lowry R; Sussman S; Dent CW
    Arch Pediatr Adolesc Med; 2001 Sep; 155(9):1043-50. PubMed ID: 11529807
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A social cost-benefit analysis of meat taxation and a fruit and vegetables subsidy for a healthy and sustainable food consumption in the Netherlands.
    Broeks MJ; Biesbroek S; Over EAB; van Gils PF; Toxopeus I; Beukers MH; Temme EHM
    BMC Public Health; 2020 May; 20(1):643. PubMed ID: 32389120
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Application of a system dynamics model to inform investment in smoking cessation services in New Zealand.
    Tobias MI; Cavana RY; Bloomfield A
    Am J Public Health; 2010 Jul; 100(7):1274-81. PubMed ID: 20466963
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cost-effectiveness of a tobacco 'quit and win' contest in Sweden.
    Tillgren P; Rosén M; Haglund BJ; Ainetdin T; Lindholm L; Holm LE
    Health Policy; 1993 Nov; 26(1):43-53. PubMed ID: 10130845
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Addressing the Social Determinants of Health to Reduce Tobacco-Related Disparities.
    Garrett BE; Dube SR; Babb S; McAfee T
    Nicotine Tob Res; 2015 Aug; 17(8):892-7. PubMed ID: 25516538
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cost-effectiveness of financial incentives for smoking cessation in pregnancy.
    Boyd KA; Tappin DM; Bauld L
    Addiction; 2016 Jun; 111(6):115-7. PubMed ID: 27157899
    [No Abstract]   [Full Text] [Related]  

  • 95. Are anti-smoking social norms associated with tobacco control mass media campaigns, tax and policy changes? Findings from an Australian serial cross-sectional population study of smokers.
    Durkin SJ; Schoenaker D; Brennan E; Bayly M; Wakefield MA
    Tob Control; 2021 Mar; 30(2):177-184. PubMed ID: 32269172
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Socioeconomic differences and smoking: clear connections with implications for tobacco policy].
    Kunst AE
    Ned Tijdschr Geneeskd; 2017; 161():D1530. PubMed ID: 28401823
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cost-effectiveness of tobacco control policies and programmes targeting adolescents: a systematic review.
    Leão T; Kunst AE; Perelman J
    Eur J Public Health; 2018 Feb; 28(1):39-43. PubMed ID: 29267928
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Cost-effectiveness of smoking cessation to prevent age-related macular degeneration.
    Hurley SF; Matthews JP; Guymer RH
    Cost Eff Resour Alloc; 2008 Sep; 6():18. PubMed ID: 18783631
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Selected aspects of tobacco control in Croatia.
    Loubeau PR
    Cent Eur J Public Health; 2009 Mar; 17(1):47-52. PubMed ID: 19418720
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Dutch tobacco control policy: milestones in the past and a look into the future].
    Willemsen MC
    Ned Tijdschr Geneeskd; 2017; 161():D949. PubMed ID: 28270238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.